Medisse, a Dutch biomaterial firm, has announced that it has raised €2.6m ($3.5m) in a series B round led by life science investor IIG with participation from existing backers Omnes Capital and University of Leiden-backed BioGeneration Ventures.

In addition to the €2.6m ($3.5m), Medisse will also receive an unspecified sum in the form of innovation credit from the Dutch Ministry of Economic Affairs.

The latest round of financing will be used by Medisse to further develop its lead product, an…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?